MedPath

MR imaging biomarkers associated with patient-reported xerostomia post-RT

Recruiting
Conditions
Speekselklier schade naar aanleiding van hoofdhals radiotherapie
dry mouth syndrome
Xerostomia
Registration Number
NL-OMON54312
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
54
Inclusion Criteria

• The patients are above 18 years old and have received (chemo)radiotherapy for
primary H&N cancer with curative intent.
• Patients can be enrolled after completion of their radiotherapy treatment
months from 6 months up to 3 years.
• The patients have no previous history of surgery in H&N region.
• The patients have provided written informed consent before inclusion in the
study.

Exclusion Criteria

• The patients have adverse-indication for an MRI scan, such as claustrophobia,
pregnancy, pacemaker or implantable defibrillator, metal implants.
• Patients with psychological or somatic disorders, limiting the possibilities
for adequate follow-up.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath